Corxel
Highly Engaged Employees
Manufacturing · New Jersey, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
300 Connell Dr 2200, Berkeley Heights, N...Website
www.corxelbio.comRevenue
$14.2 MillionIndustry
About Corxel
Corxel Org Chart
Senior Director, Investor Relations
Director, Procurement
Is Corxel your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Corxel launches new products
Funding: Get notified immidiatlly once Corxel has new funding data
Check if Corxel has recently received funding, and reach out quickly before it becomes old news!
Corxel, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on Corxel recently announced quarterly report
Check out if Corxel is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Corxel
Click to see if Corxel had a recent Job posting/layoffs
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Company Profile Activity
Activity Insights
Corxel is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Corxel is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Corxel.
Most Recent Scoops
Corxel News & Media
Everest Medicines Enters into Asset Purchase Agreement with Corxel Pharmaceuticals to Develop and Commercialize LNZ100 in Greater China
SHANGHAI, June 8, 2026 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing, and commercialization of innovative therapeutics, today announced that it has entered into an Asset Purchase Agreement with Corxel Pharmaceuticals Limited ("CORXEL"). Under the agreement, the Company has acquired the rights to develop, manufacture, and commercialize LNZ100 (1.44% aceclidine, U.S. brand namEverest Medicines Enters into Asset Purchase Agreement with Corxel Pharmaceuticals to Develop and Commercialize CARDAMYSTâ„¢ (Etripamil) Nasal Spray in Greater China
SHANGHAI, March 23, 2026 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing, and commercialization of innovative therapeutics, today announced that it has entered into an Asset Purchase Agreement with Corxel Pharmaceuticals Hong Kong Limited ("CORXEL"). Under the agreement, the Company has acquired the rights to develop, manufacture, and commercialize CARDAMYSTâ„¢ (etripamil) nasal
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Corxel
CORXEL is a clinical-stage biopharmaceutical company focused on discovering and developing innovative therapies for cardiometabolic diseases to improve patient outcomes worldwide. It combines global expertise and a strong pipeline of clinical-stage assets directed at conditions such as obesity, diabetes, stroke and hypertension with a mission to ad... Read More


